{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:27:40Z","timestamp":1791278860770,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9,1]]},"DOI":"10.1086\/504485","type":"journal-article","created":{"date-parts":[[2006,8,7]],"date-time":"2006-08-07T20:11:32Z","timestamp":1154981492000},"page":"S89-S94","source":"Crossref","is-referenced-by-count":97,"title":["Parenteral and Inhaled Colistin for Treatment of Ventilator-Associated Pneumonia"],"prefix":"10.1093","volume":"43","author":[{"given":"Peter K.","family":"Linden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,9,1]]},"reference":[{"key":"key\n\t\t\t\t20171014020228_ref1","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/00003246-200112000-00012","article-title":"Mortality rate attributable to ventilator-associated pneumonia in an adult intensive care unit: a prospective case-control study","volume":"29","author":"Bercault","year":"2001","journal-title":"Crit Care Med"},{"key":"key\n\t\t\t\t20171014020228_ref2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014020228_ref3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator associated and healthcare associated pneumonia","volume":"171","author":"American Thoracic Society\/Infectious Diseases Society of America","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014020228_ref4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/338782","article-title":"Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?","volume":"34","author":"Livermore","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1378\/chest.119.2_suppl.397S","article-title":"Resistance patterns among nosocomial pathogens: trends over the past few years","volume":"119","author":"Jones","year":"2001","journal-title":"Chest"},{"key":"key\n\t\t\t\t20171014020228_ref6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1136\/thx.52.11.987","article-title":"Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis","volume":"52","author":"Conway","year":"1997","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20171014020228_ref7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1183\/09031936.98.12030592","article-title":"Four years experience of intravenous colomycin in an adult cystic fibrosis unit","volume":"12","author":"Ledson","year":"1998","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20171014020228_ref8","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/00007890-199709150-00015","article-title":"Use of aerosolized colistin sodium in cystic fibrosis patients awaiting lung transplantation","volume":"64","author":"Bauldoff","year":"1997","journal-title":"Transplantation"},{"key":"key\n\t\t\t\t20171014020228_ref9","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1086\/514732","article-title":"Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"28","author":"Levin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/374337","article-title":"Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP","volume":"36","author":"Garnacho-Montero","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/cc2358","article-title":"Intravenous colistin in the treatment of sepsis from multiresistant gram-negative bacilli in critically ill patients","volume":"7","author":"Markou","year":"2003","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20171014020228_ref12","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1086\/379611","article-title":"Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa","volume":"37","author":"Linden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref13","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.49.8.3136-3146.2005","article-title":"Combination therapy with intravenous colistin for management of infections due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis","volume":"49","author":"Kasiakou","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00063198-200111000-00013","article-title":"The clinical use of colistin in patients with cystic fibrosis","volume":"7","author":"Beringer","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"key\n\t\t\t\t20171014020228_ref15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/jac\/19.6.831","article-title":"Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection","volume":"19","author":"Jensen","year":"1987","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0954-6111(94)90028-0","article-title":"Nebulized colistin causes chest tightness in adults with cystic fibrosis","volume":"88","author":"Maddison","year":"1994","journal-title":"Respir Med"},{"key":"key\n\t\t\t\t20171014020228_ref17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1136\/adc.84.5.432","article-title":"Bronchoconstriction following nebulised colistin in cystic fibrosis","volume":"84","author":"Cunningham","year":"2001","journal-title":"Arch Dis Child"},{"key":"key\n\t\t\t\t20171014020228_ref18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/cc3020","article-title":"Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis","volume":"9","author":"Michalapoulos","year":"2005","journal-title":"Crit Care"},{"key":"key\n\t\t\t\t20171014020228_ref19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1164\/ajrccm.162.1.9910071","article-title":"Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin","volume":"162","author":"Hamer","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20171014020228_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-5-1","article-title":"Toxicity after prolonged (more than four weeks) administration of intravenous colistin","volume":"5","author":"Falagas","year":"2005","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref21","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1128\/AAC.38.3.547","article-title":"Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin","volume":"38","author":"Fink","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref22","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/514760","article-title":"Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa","volume":"28","author":"Harris","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1086\/339488","article-title":"Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms","volume":"34","author":"Trouillet","year":"2002","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","article-title":"Emergence of antibiotic resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents","volume":"43","author":"Carmeli","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref25","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1128\/AAC.41.5.1127","article-title":"Monotherapy versus beta-lactam-aminoglycoside treatment for gram-negative bacteremia: a prospective observational study","volume":"41","author":"Leibovici","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ppul.10166","article-title":"Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center","volume":"34","author":"Denton","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"key\n\t\t\t\t20171014020228_ref27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(72)91568-1","article-title":"Tetracycline-sensitive\/polymyxin-resistant Pseudomonas aeruginosa [letter]","volume":"1","author":"Brown","year":"1972","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171014020228_ref28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/AAC.26.4.539","article-title":"Evidence for two distinct mechanisms of resistance to polymyxin B in Pseudomonas aeruginosa","volume":"26","author":"Moore","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref29","article-title":"Performance standards for antimicrobial susceptibility testing","volume-title":"12th informational supplement. NCCLS document M100-S12","author":"National Committee for Clinical Laboratory Standards","year":"2002"},{"key":"key\n\t\t\t\t20171014020228_ref30","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/JCM.39.1.183-190.2001","article-title":"Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines","volume":"39","author":"Gales","year":"2001","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20171014020228_ref31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0732-8893(01)00258-9","article-title":"Interaction of colistin and rifampin on multidrug-resistant Acinetobacter baumannii","volume":"40","author":"Giamarellos-Bourboulis","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171014020228_ref32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1179\/joc.2003.15.3.235","article-title":"In vitro interaction of colistin and rifampin on multidrug-resistant Pseudomonas aeruginosa","volume":"15","author":"Giamarellos-Bourboulis","year":"2003","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref33","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/AAC.47.3.905-909.2003","article-title":"Synergistic activity of colistin and ceftazidime against multiantibiotic resistant Pseudomonas aeruginosa in an in vivo pharmacodynamic model","volume":"47","author":"Gunderson","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171014020228_ref34","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1345\/aph.18426","article-title":"Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria","volume":"33","author":"Feola","year":"1999","journal-title":"Ann Pharmacother"},{"key":"key\n\t\t\t\t20171014020228_ref35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM196204122661505","article-title":"Neurotoxic and nephrotoxic effects of colistin in patients with renal disease","volume":"266","author":"Wolinsky","year":"1972","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014020228_ref36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-72-6-857","article-title":"Adverse effects of sodium colisimethate: manifestations and specific rates during 317 courses of therapy","volume":"72","author":"Koch-Weser","year":"1970","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20171014020228_ref37","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bmj.4.5734.525","article-title":"Effects of large doses of colistin sulphomethate sodium on renal function","volume":"4","author":"Price","year":"1970","journal-title":"Br Med J"},{"key":"key\n\t\t\t\t20171014020228_ref38","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5694\/j.1326-5377.1970.tb63262.x","article-title":"Acute renal failure due to overdosage of colistin","volume":"2","author":"Brown","year":"1970","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t20171014020228_ref39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM196204122661505","article-title":"Hines JD. Neurotoxic and nephrotoxic effects of colistin in patients with renal disease","volume":"266","author":"Slinsky","year":"1962","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171014020228_ref40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1056\/NEJM197509042931003","article-title":"Aerosol polymyxin and pneumonia in seriously ill patients","volume":"293","author":"Feeley","year":"1975","journal-title":"N Engl J Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/43\/Supplement_2\/S89\/20907694\/43-Supplement_2-S89.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,17]],"date-time":"2020-04-17T20:07:11Z","timestamp":1587154031000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cid\/article\/43\/Supplement_2\/S89\/333841\/Parenteral-and-Inhaled-Colistin-for-Treatment-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,1]]},"references-count":40,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2006,9,1]]},"published-print":{"date-parts":[[2006,9,1]]}},"URL":"https:\/\/doi.org\/10.1086\/504485","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2006,9,1]]},"published":{"date-parts":[[2006,9,1]]}}}